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THE GERMAN HEALTHCARE SYSTEM
Döring A, Paul F
NeuroCure Clinical Research Center, Charité–Universitäts-
medizin Berlin, Germany
Germany’s healthcare system is a contribution-based
social insurance model, whose main features can be traced
back to the beginning of the Middle Ages and even
earlier. It is an important economic area and, with its
large workforce of approximately 4.3 million employees
(status in 2007), also plays a key role in labor market
policy.
In its current form, the German healthcare system is extremely
complex and which even experts find difficult to grasp. The
foundation of Germany’s healthcare system is derived from
Germany’s Basic Law (Grundgesetz), which obliges the state
to provide social services to its citizens (Article 20, 28, of the
Basic Law). Specifically, the state must ensure sufficient,
needs-based ambulatory and inpatient medical treatment, in
qualitative and quantitative terms, as well as guarantee the
provision of medicine. The federal government may assume
this duty itself or delegate it to state governments and
institutions in the form of service guarantee contracts (§ 72,
German Social Insurance Code, Book V).
Basic principles of social rights are used as the framework for
ensuring social security in cases of illness, and must be
followed by both the health insurance companies and health
service providers. The principle of the welfare state is based on
the Federal Republic of Germany’s Basic Law (Grundgesetz),
which specifies that the state must guarantee all citizens social
Fig. 1. The structure of the German healthcare system [1]
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justice and the equal participation in society, including
appropriate treatment in case of illness. Individuals with below
average earning power or economic resources must receive the
same quality and quantity of medical care as others. Thus,
overall, the healthcare system is organized around the principle
of solidarity (Solidarprinzip), which provides that every
member of a supportive society is entitled to assistance from
the other members of the society in the case of illness. A main
feature of the statutory health insurance scheme is social
reconciliation (Solidarausgleich), which is expressed in two
main ways: firstly, between the healthy and ill, in that all
members–including the healthy–meet the costs of the neces-
sary treatment and benefits if a member falls ill regardless of
the individual’s economic resources, including the additional
costs of securing the individual’s livelihood, such as continued
wages and sickness benefits; and secondly, between high and
low incomes, in that up to a defined income threshold, all
members of the statutory health insurance pay an income-
dependant percentage of their earnings. This solidarity model
stands in contrast to the subsidization principle, which
provides that an individual’s expenses are only then assumed
by the supportive society if the individual is demonstrably
overextended. Until such a point, the individual is obliged to
contribute to the treatment costs. In the subsidization model,
the healthcare expenses are met by a sequence of supportive
societies from smallest to largest: the individual, his or her
martial or life partner, the family, the statutory health insurance
fund, and finally the services the individual is entitled to as a
citizen.
The aim is to give an overview about the German healthcare
system and gain an understanding of its complexity and
principles of organisation. Please find more information about
the German healthcare system on the EPMAWorld Congress
2011 in Bonn, Germany.
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HEALTHCARE IN THE U.K.
Grosios K
University of Leeds, UK
The UK healthcare system, National Health Service (NHS),
came into existence in the aftermath of the Second World
War under the principles of universality, free at the point of
delivery, equity, and paid for by central funding. It has
evolved to become one of the largest healthcare systems in
the world. The Health Act 2009 established the “NHS
Constitution” which formally brings together the purpose
and principles of the NHS in England, its values, as they
have been developed by patients, public and staff and the
rights, pledges and responsibilities of patients, public and
staff. Scotland, Northern Ireland and Wales have also
agreed to a high level statement declaring the principles
of the NHS across the UK, even though services may be
provided differently in the four countries, reflecting their
different health needs and situations. The health research
strategy of the NHS is being implemented through National
Institute of Health Research (NIHR) and in 1999 the National
Institute for Health and Clinical Excellence (NICE) was
established as the body responsible for developing national
guidelines and standards related to, health promotion and
prevention, assessment of new and existing technology
(including medicines and procedures) and treatment and care
clinical guidance, available across the NHS.
In 2010 the publication of the White Paper “Equity and
excellence: Liberating the NHS” heralded one of the biggest
shake ups of the health system since its inception. Through the
paper the coalition government announced its strategy on how
it will “create a more responsive, patient-centred NHS which
achieves outcomes that are among the best in the world”.
Since then plans for reshaping the system have faced strong
criticism and changes remain undefined and unimplemented.
Nevertheless, the development of preventive, people-centred
(shared decision-making/ no decision about me without me)
and more productive healthcare services is being seen as keyFig. 2. The subsidization model [1]
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for the NHS to respond to the challenges that all modern
healthcare systems are facing in the 21st century.
Predictive, preventive and/or personalised medicine (PPPM)
services within the NHS have traditionally been offered and
are part of disease diagnosis and treatment. Preventive
medicine is its own established entity and relevant services,
such as cancer screening, child health promotion and
immunisation programmes, are directed by Public Health
and offered either via GP, community services or hospitals.
References to predictive and personalised medicine are
increasingly being introduced in NHS related information
and personalised therapies in the form of diagnostics and drug
therapies are commonly prescribed and used and are in-
creasingly available via commercial/private non-NHS routes.
Implementation of PPPM interventions may provide solutions
to many of the challenges that healthcare in the UK is facing.
This is in turn creating a new way of thinking and set of
standards and generates new dilemmas and issues that need to
be resolved considering multiple aspects such as disease and
health evolution and scientific understanding, professionals
and public expectations and education, technological ad-
vancement and wider health policies, regulations and financial
environment.
HEALTHCARE OVERVIEW: EUROPEAN
AREA & GLOBAL SCALE
Iso H
National Representative of EPMA in Japan
Healthcare for cardiovascular prevention and treatment in
Japan is overviewed because the decline in cardiovascular
disease in particular stroke since the 1960s has contributed
to achieve one of the longest life expectancies in the world.
The national prevention program for cardiovascular disease
was launched in 1982 under the Health Service for the
Elderly Act based on the establishment of national health
insurance coverage since 1961. Under this Act, insurers are
municipal governments and are financed with help from
prefectural and national governments to conduct health
screening and health education for residents aged 40 and
over, as well as care for the aged. The Industrial Safety and
Health Act since 1972 has assured health screening and
education for company employees. The universal insurance
coverage and health screening and education system enhanced
the hypertension control and lifestyle modification for high-
risk individuals in company and community settings.
Meanwhile, the national government performed a series of
revisions to the Medical Care Act in 1985, 1992, 1997, and
2000 to control the number of beds, to differentiate hospital
roles as high-technology hospitals, long-term care hospitals,
and regional tertiary hospitals, to emphasize the importance
of informed consent and staff training, and to enhance
amenities. That act has improved the operation of local
ambulance system that allowed patients with acute cardio-
vascular events such as stroke and heart attack admitted
quickly to local acute care hospitals.
Because of rapid aging and high medical costs for the
elderly, the national government amended the Long-term
Care Insurance Act in 1997 and the Health Promotion Act
in 2002 to improve people’s lifestyles in line with the goals
set out in Healthy People Japan 2000.
In 2006, the Japanese government amended a reform act
regarding the health care system for the prevention and
treatment of lifestyle-related diseases to slow down the rise
in medical expenditure. The Health Service for the Elderly
Act since 1982 has evolved into the Elderly Health Care
Security Act, where the health insurer is a central health
care provider body rather than municipal governments.
Under this Act, the emphasis is placed on the prevention
and control of metabolic syndrome where abdominal
obesity is an essential component within a constellation of
high blood pressure, dyslipidemia, and glucose abnormality.
Although persons with metabolic syndrome are at high risk
of ischemic stroke and IHD, non-obese persons with high
blood pressure, dyslipidemia, or glucose abnormality have a
similar or higher prevalence, and are also at high risk.
The threat of increasing incidence of IHD among urban
men may justify the recent amendment of the Elderly
Health Care Security Act, focusing on preventive and
control activities targeting metabolic syndrome. However,
it should be noted that the public health burden of cardio-
vascular disease was equal or even greater among non-
obese high-risk individuals compared with obese high-risk
individuals. The Elderly Health Care Security Act focusing
on metabolic syndrome needs to be re-evaluated and
modified in the near future.
AN OVERVIEW OF THE HEALTHCARE SYSTEM
IN THE SLOVAK REPUBLIC FOCUSED ON THE
INPLEMENTATION OF PREDICTIVE, PREVENTIVE
AND PERSONALISED MEDICINE
Kapalla M1,2, Kapallová D1,2, Turecký L3
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Healthcare system in the Slovak Republic is neither
Bismarck nor Beveridge nor National Health Insurance
model, although it has certain features of all. The
healthcare contributions are mandatory and are paid to
the health insurance company. Almost 100% solidarity is
implemented in the system–people who earn more, pay
more, those who earn less pay less, but all receive the
same healthcare. There are also healthcare providers who
offer their services that are not reimbursed from the
health insurance and are paid cash by the patient.
Virtually, an insured citizen is not limited as for the
amount of the healthcare spending per period of time, on
the other hand, the reimbursement limits are set for the
particular healthcare providers. According to the data
from the health insurance companies, over 98% of the
population is covered by the health insurance. Public
healthcare expenditure has been approximately 3400
millions € in 2009, which represents around 5.36% of
gross domestic product. Another 1000 millon € in cash is
estimated to be spent on health-related products and
services. In total, around 7 % of gross domestic product
is spent in healthcare. On the basis of the statistical data,
around 78% of the 5.4 million population may be
regarded to as relatively healthy, or having no apparent
health problems. The 22% of the population suffer of the
most common diseases such as cardiovascular diseases,
diabetes, respiratory diseases, psychiatric diseases, infec-
tious diseases and cancer. The National Health Promotion
Programme states the objectives related to improving the
health status in the Slovak Republic. The tools for
fulfilling the goals include early prediction, prevention,
and education, which is in a good agreement with
the concept of predictive, preventive and personalised
medicine. The healthcare system in the Slovak Republic
has the potential of being substantially better if wisely
governed in the years to come (Figure 1). New
government has now a unique opportunity to implement
the concept of the predictive, preventive and personalised
medicine into the healthcare system of the Slovak
Republic for the benefit of each citizen and consequently
for the entire country. The contacts between EPMA and
the Ministry of Health of the Slovak Republic have been
established in order to actively initiate the changes
needed. The proposed changes include, among other,
the following activities:
& more emphasis should be put on the modern laboratory
diagnostics and in-vivo diagnostics and their predictive
potential
& implement PPPM education programmes at the appropri-
ate levels of education system in the Slovak Republic
& emphasise the role of the healthy nutrition and
implement the technology for fast, affordable and
convenient analysis of the individual food
& motivate people who do take care of their own health
& stress the personalised aspect of the healthcare, treat the
individual patient not the statistical entity called “public
health”
& allocate financial resources now and they will return in
the lower healthcare spending in the future
& decrease the consumption of medical drugs
& set new standards for quality in healthcare at all levels–
prepare the profile of the desired healthcare provider in
the particular service (GP, Specialist, Clinical Laborato-
ry, Hospital, Health Insurance, Pharmacy, Emergency
medical service, other related services such as educa-
tion, medical research)
OVERVIEW OF TURKISH HEALTHCARE SYSTEM
Dundar M
Erciyes University Medical Faculty, Department of Medical
Genetics, Talas, Kayseri, Turkey
Turkey—one of the most geostrategical countries in the
world–is situated at the crossroads of the Old World, Asia,
Europe and Africa. It is a major bridge not only between
the civilizations of the West and the East but also the main
religions followed by billions of people.
Turkey’s population recorded as 67.804.000 in 2000,
rose to 73.722.988 by 2010. Of this population, males
constitute 35.901.154 (50.1%) and females 35.615.946
(49.9%). According figures registered in 2005, life expec-
Fig. 1. “Healthcare clock”—a brief visualisation of the healthcare in
Slovakia from PPPM implementation point of view. Although
particular components may be assessed subjectively to certain extend,
authors used verifiable data, information and personal experience for
the reliable assessment.
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tancy is 73.8 years for women and 68.9 years for men
(Table 1).
Physicians active in healthcare are 113.151 as registered in
2008. Of these, 57.000 are specialists, 35.000 general
practitioners and 20.000 residents in various specialization
programs. Other and auxillary medical personnel consists
of 20.000 dental surgeons, 100.000 nurses, 78000 medical
technicians, 48.000 midwifes, and 25.000 pharmacists.
The public sector continues to be the primary agent for
providing healthcare. State owned, public institutions
control 92 percent of hospital beds and handle practically
all the preventive care services. Meanwhile, private health-
care and medical investments are continually encouraged
and on the grow. In addition, as registered in 2008, 830
hemodialysis centers for patients with kidney failure are in
service, compared to 443 registered in 2002.
The family physician system, first adopted in 15.09.2005
was enlarged to cover the entire country in 2010. The
system allows patients for selectnig their own family
physicians and whenever an examination is necessary, they
can apply for the doctor of own choice, free of charge
excepting actively employed persons, who have to contribute
20 % of the cost of any medication prescribed by the family
physician; the retirees’ contribution comprises 10 % of the
costs. Immunization services are carried out by the family
physicians according to a calendar routinely published by the
Ministry of Health. Families are not required to make any
payment for vaccinations.
At the basic level, Health education in Turkey is provided by
mid-level vocational high schools. Then there are vocational
colleges attached to universities and at the top, faculties of
medicine that raise the physicians. According to the figures of
the Higher Education Council, there are 64 Faculties of
Medicine in Turkey, 10 in private and 54 in state universities.
Health and medical care consequently became more
widespread and available to the general public, with such
practices as “the green card” as it is popularly called,
medical “insurance” for the indigent granted completely
free of charge in public institutions.
As for the outreach of medical services, particularly as far
as medium and less developed nations are concerned, one
most efficient and cost effective method in curbing disease
and improving both public and personal health is socializ-
ing medical care and spreading preventive medicine to
cover larger areas and populations. Turkey’s demographic
pressures necessitate a comprehensive medical care that
requires a larger number of general practitioners but the
statistics cited above indicate a serious, if not severe
narrowing at the bottom of the pyramid: specialists almost
outnumber GPs. Although being free, current healthcare is
a subject for further improvements in parallel to essential
cultural developments essential to be carry out in the
society.
Table1: Demographic Data
Years 2000 2007 2008
Population (x1000) 67.804 70.586 71.517
Rural Population (%) 35.1 29.5 25.0
Urban Population (%) 64.9 70.5 75.0
Annual Population Growth Rate (%) 13.8 11.8 11.5
Crude Death Rate (%) 6.6 6.4 6.4
Crude Birth Rate (%) 20.3 18.1 17.9
THE FRENCH HEALTHCARE SYSTEM IN
OVERVIEW
Pinçon-Raymond M
93 Route des Gardes, 92190 Meudon, France
The French’s healthcare system is totally governed by the
law “Bachelot Hôpital, Patients, Santé et Territoires” or law
HPST (n° 2009–879 July 21 2009).
The ambition of the law is to reorganize totally the
healthcare system: hospital, distribution of general practi-
tioners and private/public access to the cares, public health
and prevention, creation of Regional agencies of Health
(ARS: Agence Régionale de Santé) in charge of territorially
coordination of the health politics (hospital, medicine
practices in town, public health and prevention).
The hospital: reorganisation of the assignment and modifi-
cation of the health institution’s statutes.
Distribution: organisation with different levels of care
according to the need of the population. The financial
participation of the insured patient is required in specific
cases.
Public health and prevention: creation of a new agency in
charge of the sanitary security, food, environment and work.
A particular attention will be made to the side effects of
drogues, and therapeutic education of the patients.
ARS: organises the care access and is in charge of the
continued health trail of the patient. The ARSs are funded
by state contribution, health insurance and local community.
The ministry of superior education and health defines the
medical formation: territorial regulation of the number of
house doctor positions according to the demography and
medical specialities needed.
CURRENT HEALTHCARE IN BULGARIA
Dimitrov DV1, Georgieva T2, Petrov K2
1Medical University Varna, Varna, Bulgaria
2Health Commission, Bulgarian Parliament
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Since the health system restructuring, Bulgarian health
providers are mainly reimbursed prospectively for the
services they will provide to the population on a per-case
and per-capita basis. This means that actual payment rates
are agreed in the contract before the treatment takes place.
Each year the National Health Insurance Fund (NHIF),
together with the Bulgarian Medical and Dentists Unions,
negotiates payment mechanisms to the health facilities
contracted with the NHIF. Some types of health provider
receive fee-for-service payments, which are a typical form
of retrospective reimbursement.
Primary care is provided in private practices, group
practices and at outpatient departments. The General
Practitioner (GP) is the owner of a private practice and a
group practice is owned by its founders. If physicians want to
work in the outpatient sector, they are statutorily required to
register to provide either primary or outpatient specialized
care in either single or group practices; or to be employed by a
diagnostic and consultative centre, a medical centre, a dental
centre, or a medical and dental centre.
Hospitals receive funding mostly through case-based pay-
ments (clinical pathways). An Australian like model, the
clinical pathways, was introduced in 2001 as part of the
National Framework Contract, based on a single flat rate
per pathway. In 2001 there were 158 diagnoses grouped in
30 clinical pathways. Government human resources are
assigned to health facilities in accordance with the National
Health Map, which specifies by region target numbers of
health care professionals per institution. The country will be
divided into six regions, each of which will have all types
of hospitals. The six regions, which split the country are:
North, North Central, North Eastern, South, South Central
and Southeast. The aim is that every one of them has all
kinds of hospitals–from the GP offices to the most high-
tech hospitals, so everyone will be able to quickly reach the
required medical attention. New unified electronic system
for the healthcare is planned to start 2012. It will facilitate
communication between different parties (health insurance,
hospitals, GPs and patients) and will reduce costs and
waiting hours.
The future directions include medical tourism, e.g. for spa and
rehabilitation, but also early disease screening enabling
personalized medicine that will give advances in public health.
EPMA IN SPAIN: A CHALLENGE FOR FUTURE
Mendive JM1, González Neira A2
1European Medical Association, Barcelona, Spain
2Centro Nacional para la Investigación Oncológica (CNIO),
Madrid, Spain
A new structure for the development of the EPMA-related
activities is recently being established in Spain. Main
aims of the Spanish EPMA network are both to act as
national platform for activities on Preventive, Predictive
and Personalized Medicine and to provide an international
dimension of those activities, acting always on the basis of
the international EPMA association and taking into account
the importance of providing this international association,
an active Spanish network.
To guarantee those aims, Spanish National EPMA Board is
being organizing with the presence of relevant people on
the on fields of Preventive, Predictive and Personalized
Medicine in Spain. The structure of EPMA in Spain is
taking into account different institutions, including medical
scientific associations with special relevance on research
activity as well as medical professional associations and
official institutions. Other partners are including possible
future private research institutions as partners to guarantee
the Spanish EPMA activities. Among these it is being held
an active coordination of the advisory board to support a
strategic plan of activities that have a promising future of
EPMA in Spain.
GEORGIAN HOSPICE MOVEMENT—2000–2011:
CHRONOLOGY OF THE KEY EVENTS
Rukhadze T, Velijanashvili M, Alibegashvili T, Kordzaia D
Georgian National Association for Palliative Care, Chiaureli
st. 0157 Tbilisi, Georgia
During the period 2000–2010 in Georgia, through the
permanent collaboration of devotees with Governmental
Institutions and NGOs (including International Organizations
and Experts) the basis for the development of Palliative Care
as an integral part of National Healthcare System was created.
It is confirmed by:
& Establishment of “Palliative Care” educational materials
in Georgian language, Creation of “Palliative Care”
educational programs and their implementation in
Medical Universities and Nursing Schools;
& Preparation and implementation of “Palliative Care”
CME accredited programs;
& Organization of Hospices (in-patients units for PC) and
Home-Based Palliative Care Teams and their financial
support by governmental budget;
& Creation of “ Palliative Care National Program Coor-
dinator’s Office” at the Committee of Labor, Health and
Social Affairs of The Parliament of Georgia;
& Preparation of Video/TVand printed materials for public
education and awareness;
& Improvement of Legislative-Normative Basis regulating
Palliative Care and Drug Availability and promoting
Palliative Care incorporation in National Healthcare
system of Georgia.
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On April 08, 2007 the amendments in 4 laws of Georgia
were approved by Parliament of Georgia:
– Palliative Care was recognized as an integral part of
continuous medical aid
– Provision of narcotics and psychotropic substances in
required (needed) amount and forms–for medical,
scientific and other needs–according to international
standards–was recognized as state obligation.
On July 10 of 2008, the Decree of Minister of Labor, Health
and Social Affairs of Georgia was issued “On Approval of the
Instruction of Palliative Care for Chronic Incurable Patients”.
This decree includes the following topics:
– Single prescription can cover opioids for 7 days;
– Opioids can be prescribed for chronic or acute pain
diagnosis;
– All medical doctors can prescribe opioids after passing
special training course;
& Preparation of the medical professionals experienced in
PC, including two international fellows (experts).
& Strategy document Georgian National Program for
Palliative Care (Action Plan for 2011–2015) was
approved by the Parliament of Georgia.
PREVENTIVE, PREDICTIVE, PERSONALIZED
ANDPARTICIPATORY (P4)HEALTHCARE IMPACTED
BY CLIMATE, CULTURE AND COMMUNITY IN THE
COMPUTERIZEDWORLD
Gozes I1, Marcus-Kalish M2
1Department of HumanMolecular Genetics and Biochemistry,
Sackler School of Medicine, Tel Aviv University, Israel
2Interdisciplinary Center for Technology Analysis and
Forecasting, Tel Aviv University, Tel Aviv 69978, Israel
The goal of Preventive, Predictive, Personalized and Partic-
ipatory healthcare (“4P”) is to lay the strategic refined ground
to ushering in a new era of wellbeing and epochal revolution
in healthcare to the citizens of Europe and the world. A
profound systematic attempt to extract, define, and analyze
all relevant factors both inside and outside the body based on
the interplay of all scientific disciplines while conveying
knowledge tools and expertise. The attempt is to combine the
“4P” with the “4C” surrounding factors including Climate,
Culture and Community in the Computerized world. Our
vision is that the time has come to relate to the individual
within the natural and artificial surroundings as one complex
functioning system (Figure 1). To further these studies, a
special scheme of discussion, will be applied. The CHEST–
Converging Humanities, Education, Science and Technology
methodology will enable placing and tackling the barriers
while sharing and converging all concepts, tools and
knowhow in a structured well documented procedure.
A systematic analysis including the various treatments and
drugs is warranted focusing first on 5 major disease types
including brain diseases (e.g. Alzheimer’s disease, depres-
sion and schizophrenia), metabolic, cardiovascular, cancer
and infectious diseases to reduce drug adverse effects.
These studies will lay the grounds for better understanding,
prevention and therapeutics of other diseases as well. A
multilayer system, envisioned in a conceptual matrix
approach, will be incorporated to analyze all possible
factors in three layers: the healthy population, patients
who were diagnosed but not treated and treated patients.
The comprehensive analysis in each of these layers (matrix)
will try to collect all parameters and effects (rows) in each
disease type (columns) while utilizing all available Infor-
mation Computerized Technologies (ICT) applied and
developed in different areas of science.
The deliverables of these innovative cross disciplinary
efforts will have a direct impact on:
& Drug efficacy yielding economic impact and reducing
world disparities.
& Individual healthcare and wellbeing fitted to the
surrounding, with broad impact from economics up to
migration and cultural clashes.
& Affordable medicine to the underprivileged population,
improving their wellbeing and better utilization of their
surrounding will reduce population migration and thus
the socio-economic impact.
& Professional and public education utilizing all devel-
oped ICT tools, starting from the medical school (thus,
reducing animal experimentation) through public edu-
cation and up to reaching citizen private home
providing health care knowledge and support.
& Science research schemes and university structure
having to restructure the research management and
education schemes towards more open and multidisci-
plinary implementation.
& Public awareness.
Partners: Prof. Manolis Tsiknakis, Prof. Dr. Michael
Hecker , Prof. Marian Joels, Prof. Dr. Bogdan Popescu,
Prof. S. Moein Moghimi, Prof. Marianne Schultzberg, Prof.
Jan A. Kors , Prof. Olga Golubnitschaja, Dr. Stefan Rüping,
Prof. Alfred Nordman, Prof. Milos Kojic, Dr. Enzo Grossi,
Prof. Dr. Claus-Michael Lehr, Prof. Jean Eve Blay, Prof.
Mauro Ferrari, Dr. Biana Vilentchouk Godin, Prof. Manuela
Arata, Dr. Karen Steinmetz, Prof.Seiji Shioda, Prof. Paulo
Milani, Dr. Julian Adams, Maurizio Mencarini, Hamutal
Meiri, Prof. Ehud Gazit, Prof. Dan Peer, Dr. David
Gurewitz, Prof. Eliora Ron, Prof. Mati Mintz, Prof. Yehuda
Bnayahu, Dr. PninaDan, Dr. Tsipi Shoham,Dr. Zohar BenAsher
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THE ROLE OF MEDICAL IMAGING IN PPPM
Krestin GP
Department of Radiology, Erasmus MC, University Medical
Center Rotterdam, The Netherlands
“Personalized Medicine” (PM) describes the concept of
delivering the right treatment to the right patient at the
right time. PM is facilitated by newly developed,
powerful technologies allowing detection of biological
events at the molecular level, even before symptoms
appear. One of the main aspects of PM will be to identify
biomarkers able to characterize a cellular alteration
leading to subclinical or manifest disease status as well
as its specific reaction to various therapeutic attempts.
This approach will lead to categorizing or stratifying
patients into smaller subgroups related to their risk or
potential treatment profiles characterized by a combina-
tion of genetic, biochemical, and even imaging bio-
markers. However, the value of medical imaging in PM
is frequently underestimated, as many policy makers
forget the all-important ‘right location’ in the PM
paradigm.
Medical imaging has always been personalized as it
provides individual assessment of the location and
extent of an abnormality, and in the future it will prove
fundamental to almost all aspects of PM. Stratification
based on imaging biomarkers can help identify individ-
uals for preventive intervention and can improve disease
staging. In vivo visualization of loco-regional physio-
logical, biochemical, and biological processes using
molecular imaging can detect diseases in pre-
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Fig. 1. The Operation flow chart: Multilayer interactions between diverse disiplines will be mediated via a novel superior integrated knowledge
based ICT platform and meeting methodologies, e.g. CHEST: The CHEST approach was developed and validate as a novel highly potent
methodology tool for Converging Humanities, Education, Science & Technologies during meetings and workshops discussions, promoting barriers
tackling, solution driven discussions and diverse initiatives towards a profound multilevel understanding.
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delivery. Furthermore, imaging is essential to patient-
tailored therapy planning, therapy monitoring, and
follow-up of disease progression, as well as targeting
non-/minimally-invasive treatments, especially with the
rise of theranostics. Therefore to reach the highest potential of
PM, medical imaging must be an integral part.
INTERNATIONAL CLINICAL RESEARCH INFRA-
STRUCTURE NETWORKS TO FACILITATE MULTI-
NATIONAL CLINICAL TRIALS AND IMPLEMENT
PERSONALISED THERAPIES INTO CLINICAL
TRIALS
Gluud Ch
Copenhagen Trial Unit, Centre for Clinical Intervention
Research, Copenhagen University Hospital, Copenhagen,
Denmark; Danish National Coordinator, ECRIN
Clinical research plays the key role in the development
of health products and medical strategies, leading to
evidence-based clinical practice and healthcare cost con-
tainment. European Clinical Research Infrastructures
Network (ECRIN) is a pan-European infrastructure of
national clinical research infrastructures designed to support
multinational clinical research, making Europe a single area
for clinical trials, taking advantage of its population size to
access patients, and unlocking latent scientific potential.
ECRIN consists of 14 countries covering more than 80% of
the EU population; nine more countries are expected to join
within the next years. ECRIN has been supported by EU FP
6 and FP 7 during 2004 to 2001 (total of Euro 6.8 million).
With the support of France, Spain, Italy, and Germany,
ECRIN has obtained European Research Infrastructure
Consortium (ERIC) status. ECRIN is working for harmo-
nisation of regulatory issues and transparency in clinical
research. ECRIN started the servicing of multinational trials
in 2010, and more than six trials are presently being
conducted. ECRIN plans to expand the network and
strengthen the national partners; create a common European
culture among professionals and patients communities;
support cross-border connection of investigation net-
works; develop data management and monitoring tools
for multinational trials; and make funding available for
multinational clinical trials. The expansion includes
other world regions, forming the basis for global trials.
Such organisation will improve Europe’s attractiveness
for investigator and industry trials, boost its scientific
competitiveness, and result in better healthcare.
Randomised clinical trials are at the top of the evidence
hierarchy. The weakness of most randomised trials is that
they usually only tell us the outcome of groups of
participants randomised to one intervention or the other,
giving us a summary of an effect on groups of participants,
not information on how the individual responds. Personal-
ised therapies offer what we all request: an in depth,
personalised assessment of our heath status and a person-
ally tailored approach to improve or remove any medical
problems. If personalised medicine offers ‘parachute-like’
intervention effects, then randomised trials may not be
needed. However, most personalised therapies are likely
to offer limited benefit to a restricted group of patients.
Such effects are hard to detect. Therefore, personalised
medicine must–like other interventions–undergo rando-
mised clinical trials before they can be implemented. We
need to demonstrate that the personalised approach is
offering more benefits than harms compared with the
group-based approach. Therefore, when personalised
therapeutic interventions show promise in phase II
clinical trials then they should undergo proper assess-
ments in large phase III randomised trials compared with
the more simple group-based approach. Only in this way
can we assure that the personalised approach is offering
the benefits it promises.
ECRIN is poised to offer infrastructures for the conduct
of multinational trials on personalised therapies. You just need
to contact your national coordinating hub represented by your
national ECRIN European Correspondent (www.ECRIN.org).
IMPLEMENTATION OF PERSONALIZED HEALTH-
CARE IN HEALTH SERVICES IN THE CONTEXT
OF PUBLIC HEALTH GENOMICS–LOOKING FOR
THE BROADER PICTURE
Cesuroglu T, Brand A
Institute for Public Health Genomics, Maastricht University,
The Netherlands
The recent developments in basic sciences and health
sciences as well as related technologies offer new
opportunities for the promotion of population health.
This will challenge the healthcare delivery systems in a
fundamental way. There is a need for a shift from
general recommendations to populations and “one size
fits all” strategies towards more personalized interven-
tions in health care. The medicine of the modern world
will be Predictive, Personalized, Preemptive/ Preven-
tive, and Participatory, as defined with ‘4 P’s of
Medicine’ or ‘P4 Medicine’. Applications of P4 medi-
cine, in particular personalized medicine, combined with
the advent of health information technologies in clinical
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practice provide a new kind of medical care: personal-
ized healthcare. It is health care that works better for
each individual, based partly on scientific information
that is new and partly on technology to make complex
information useful.
GENAR Institute for Public Health and Genomics Re-
search, Ankara, Turkey, was established in 2004 as the third
public health genomics research centre in Europe. GENAR
has developed a personalized healthcare model, called
Gentest, based on the use of public health genomics
(PHG) tools and concepts to stratify individuals according
to risk groups, prevent diseases and detect them early. It
has been piloted as a health service to more than 500
individuals since 2008 and was identified as the best
practice model for public health genomics in Europe by
the Public Health Genomics European Network (PHGEN)
in 2008.
In order to reach the larges coverage and the maximum
benefit, the major implementation area of such a
practice model is the primary care services in the
context of public health. An important part of the
European health systems have publicly organized pri-
mary care services and the major challenge of imple-
mentation of such a model lies in such settings. One of
the important problems in the area of implementation of
personalized health care is that the concepts, categories,
properties, dimensions and relationships forming the
ground for implementation of personalized health care
in health services, in particular publicly organized
primary care is not properly described in the literature.
This contribution focuses on the issue.
PREVENTION AND EARLY DIAGNOSIS OF NON-
COMMUNICABLE DISEASES THROUGH THE USE
OFAPPROPRIATE HEALTH TECHNOLOGY
Maksimovic R, Li Y, Velazquez Berumen A
Diagnostic Imaging and Medical Devices Unit
Essential Health Technologies Department, World Health
Organization, 20, via Appia, M13, 1211 Geneva 27,
Switzerland
Introduction: The four main noncommunicable diseases
(cardiovascular disease, cancers, chronic respiratory dis-
eases and diabetes) lead to an estimated 35 million deaths
each year, with 80% of these deaths occurring in low- and
middle- income countries. This number is projected to
increase in the future, especially in the African and Eastern
Mediterranean regions. Prevention and early diagnosis of
these diseases through the use of appropriate health
technology can save lives. Policies should exist to ensure
equitable access to essential health technologies.
Methods: The 53rd World Health Assembly in May 2000
conceived the Action Plan for the Global Strategy for the
Prevention and Control of Noncommunicable Disease. This
plan is based on current scientific knowledge, available
evidence and a review of international experience. It
builds upon the WHO Framework Convention on
Tobacco Control and the WHO Global Strategy on
Diet, Physical Activity and Health. Building upon this
concept, the 60th World Health Assembly passed a
resolution on health technologies, recognizing the need
to establish priorities in the selection and acquisition of
medical devices, and the need to ensure proper use of
resources through planning, assessment, acquisition and
management. In April 2011, the First Global Ministerial
Conference on Healthy lifestyles and noncommunicable
disease control met with an agenda to push forward
equitable access to health technology.
Results: The Action Plan for Noncommunicable Diseases
targets the four main noncommunicable diseases through
control of four shared risk factors: tobacco use, physical
inactivity, unhealthy diets and harmful use of alcohol. The
objectives of the action plan are to: 1. Raise awareness of
the priority of noncommunicable disease in development
work at the global and national levels, 2. To establish and
strengthen national policies for prevention and control of
noncommunicable diseases, 3. To promote interventions
to reduce the main shared modified risks factors for
noncommunicable diseases, 4. To promote research for
the prevention and control of noncommunicable diseases,
5. To promote partnerships for the prevention and control
of noncommunicable diseases, and 6. To monitor non-
communicable diseases and their determinants. For each
objective, the Action Plan outlines proposed actions for
the Secretariat, Member States, as well as International
Partners. The role of health technologies in achieving these
objectives is outlined in the 60th World Health Assembly
health technologies resolution. Countries are urged to
collect, verify, update and exchange information on medical
devices and to formulate appropriate national strategies.
They are urged to draw up national and regional guidelines
for good manufacturing and regulatory practices, to
establish the necessary collaborations and centers of
technology, and to collect information that inter-relates
medical devices with public health infrastructure.
Conclusion: Low- and middle-income countries share a
majority of the burden of noncommunicable disease, and
the incidence continues to rise disproportionately in these
countries. The WHO seeks to raise the awareness of the
use of appropriate, affordable technology, particularly
diagnostic imaging technology, for the prevention and early
diagnosis of noncommunicable disease.
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HEALTH–NCP–NET
Kinkorová J
Health NCP of the Czech Republic
This project is a Coordination Action for Reinforcing the
Health National Contact Points Network in the 7th Framework
Programme for Research and Development, 2007–2013. It
has been running since May 2008 and will end in April 2012.
This project has received a total funding of XXX euros.
Health–NCP–Net is the network of officially appointed
Health National Contact Points (NCPs) and Contact Points
in International Cooperation Partner Countries (ICPC CPs).
THe consortium consists of 19 partners; the coordinator is
Instituto De Salud Carlos III, ISCIII, Spain.
The objective of HEALTH-NCP-NET is to improve NCPs’
services under FP7 across Europe, as well as in ICPC
countries by providing a more consistent NCP support that
will finally result in a higher quality of submitted proposals
into topics for the Health priority by applicants. The aim is
to develop a standard method of work, whilst keeping in
mind that diversity exists between NCP systems per
country; these can vary in structure, personnel, funding
schemes and advising capacity.
The mission of the project is to provide all Health NCPs
and ICPC CPs with the necessary tools, guidelines, advice
and support to carry out their duty efficiently and, most
importantly, to be part of a dynamic network. Health–NCP–
Net offers training sessions and encourages the exchange of
experiences and best practices amongst NCPs enabling
them to learn from each other’s experience.
The activities in the context of the Health–NCP–Net project
are mainly benchmarking, networking, transnational bro-
kerage events and the training programs. It is in the spirit of
the project partners to share the existing know-how and to
utilize already existing resources.
Attention is given to less experienced NCPs as well as to
Contact Points in ICPCs, so that they rapidly acquire the know-
how accumulated in other countries to perform their work
efficiently. An effort is devoted to identify and involve in the
network all official FP7 contact points from the ICPCs and to
promote the enlarging of the network by setting up new contact
points for Health in countries where these are not yet present.
SALUTOGENESIS AND AYURVEDA: INDICATIONS
FOR PUBLIC HEALTH MANAGEMENT
Morandi A1,2, Dalla Libera D1,2,3
1Ayurvedic Point, C.so Sempione 63, 20149 Milan, Italy
2SSIMA, Italian Scientific Society for Ayurvedic Medicine,
C.so Sempione 63, 20149 Milan, Italy
3IRCCS San Raffaele, DIMER, Dept of Neurology, Via
Olgettina 48, 20132 Milan, Italy
Ayurveda (from Sanskrit “Science of Life”)—the ancient
Traditional medicine native to India- describes health as
“stability in the true self” (swastha), a state of complete,
balanced, physical, mental and spiritual well-being [1]. This
remind us to United Nations’ World Health Organization’s
definition of health as “a state of complete physical, mental,
and social well-being and not merely the absence of disease
or infirmity” [2].
In Ayurveda the focus is about the person who has a disease
not about disease itself and its concerns are maintenance of an
abiding health, preventing rather than treating diseases. This is
in accordance to what Winslow claimed in 1920 defining
public health as “the science and art of preventing disease,
prolonging life and promoting health through the organized
efforts and informed choices of society, public and private
organizations, communities and individuals” [3].
Because of the sharp increase in non-communicable disease
[4, 5] -especially on developing countries-public health has
to find strategies for prevention and control of chronic
diseases -issue of 2011 UN General Assembly- through
surveillance of cases and promotion of healthy behaviours.
Ayurveda propose a low-cost-regimen of personalized
healthy conduct according to the individual (swasthavritta)
involving lifestyle, nutrition, self-awareness and good
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relationships with other people and nature [6]. It is
necessary to build a framework that support patients’ and
family interactions at the micro-level and a well-
coordinated policy and health-care systems, with attention
to social and environmental aspects [7]. In fact, relation-
ships between individuals in turn define individual them-
selves, contributing to awareness and self-realization and
consequently, to the sense of well-being within communities.
Another aim is to develop meaningful relationships between
community members and public health practitioners. As
stated by Charaka Samhita Sutrasthana 9: 26—one of the
main Ayurvedic textbook—“ a doctor should be sympathetic
and kind to all patients”, he must consider each individual’s
perception of the world, inner “sense of coherence” and mind-
body interactions. Communication should be improved and
patient involvement enhanced, so that people are made
responsible for their health.
Public Health Management needs to promote Health
education–as announced by the 2012 WHO health report
“stimulating the generation, translation and dissemination
of valuable knowledge”- since early ages and integrate
spirituality and ethics in healthcare system. A multidisci-
plinary professional teams may be required, including
physicians specialized in public health, nutritionists,
physiotherapists, psychologists, social scientists, biosta-
tisticians, environmental health officers, public health
engineers and lawyers, sociologists, communications
officers and others [8].
Many diseases may be preventable through simple, non-
medical methods (diet, meditation, massage) since infancy,
in order to improve life quality, limit drugs use (avoiding
expensive side-effects) and reduce medical costs.
Public Health need to address health inequalities by
advocating for population-based policies that improve
health in an equitable manner. A proposal comes from
traditional medicines, both in developing countries-where
they are affordable, available, and culturally familiar- and in
industrialized countries- since their integration in healthcare
in a more holistic approach may help disease management
[9,10]. Ayurveda, being person-centered is intercultural,
meeting the needs of different populations thanks to the
universal-coverage in its roots.
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INCORPORATION OF NATIONAL CANCER CON-
TROL PLANE IN GEORGIAN HEALTH CARE
SYSTEM
Maglakelidze M, Jokhadze N, Rukhadze T, Gagua R
National Cancer Center ofGeorgia, Association of Oncologists
of Georgia, Lisi Lake, 0177 Tbilisi, Georgia
Background: Over 7.000 people are diagnosed with
cancer in Georgia annually. Every year nearly 4.500
patients die from cancer. Cancer is a second leading
cause of death and main priority in Georgian Health
Care System.
Unfortunately, 70–72% of newly revealed cancer cases
are diagnosed at stage III–IV. More than half are
resistant to treatment and rest require long term, costly
treatment, medical, social and psychological rehabilita-
tion. Many cancer patients became disabled, abandon
active lifestyle and often need a caregiver, what
constitutes a heavy burden for their families and the
public.
Objectives: The purpose was to create and present to
government Georgian National Cancer Control Plan
(NCCP). Cancer Control aims to reduce burden and
suffering from cancer by preventing exposure to risk
factors, early detection, effective treatment, pain and
symptom management of incurable patients.
Combination of different approaches involving educa-
tion, awareness, advocacy, legislation, vaccination,
screening, early detection and treatment is used to
prevent cancer incidence and mortality. The NCCP
objectives for reducing the cancer burden in Georgia
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are based on Surveillance data and the national
objectives from Cancer Registry.
Methods: The cancer professional community and policy-
makers spent a lot of time developing a comprehensive
cancer control plan. Between September and October 2010
there was an open public debate. Later, during November
2010 additional consultations on the Plan took place. In
2011 after permanent public debates and consultations final
version was adopted by Health Council. This enables to
enact certain programs and activities already in 2011. With
input from more than 20 professional, academic, and
community-based organizations that worked together 10
major goals were identified in the field of cancer control.
NCCP objectives:
& Promoting cancer data collection.
& Rise in public cancer awareness and healthy lifestyle
popularization.
& Enhancement of healthy behaviors.
& Increasing screening rates
& Improving access to the full spectrum of cancer
diagnosis and care.
& Implementation of National Diagnostic and Treatment
Guidelines.
& Increasing patient, caregiver, health care professional
awareness about issues of quality of life, increase in
access to palliation and pain control.
& Improve reporting quality of cancer incidence, mortal-
ity, and staging data.




& Treatment and Cancer Care;
& Research and Clinical Trials;
& Palliation and Quality of Life;
& Survivorship;
& Data and Surveillance.
Results: NCCP sets out comprehensive strategy in fight
against cancer. It’s the first time government adopted major
program of action linking prevention, diagnosis, treatment,
care and research. As a result several governmental
programs have been founded.
Conclusion: Although the reasons for declining cancer
rates are multifaceted, the efforts of the NCC play an
integral part. NCCP aims to reduce cancer mortality and
to influence selected behaviors that influence cancer
mortality. This new set of goals, objectives, and strategies is




AND BIOETHICAL PARADIGMS FOR PERSON-
CENTRED MEDICINE, THE ITALIAN CONTEXT
Roberti di Sarsina P1, Iseppato I2
1High Council of Health, Ministry of Health, Italy; Observa-
tory and Methods for Health, Department of Sociology and
Social Research, University of Milan-Bicocca, Italy
2University of Bologna, Italy
Abstract: In Italy the use of non-conventional medicines
(NCM) is spreading among people as in the rest of Europe.
However, in Italy, unlike that in other countries of the
European Union, at the present time the juridical/legal
status of NCM is not well established, mainly due to the
lack of any national law regulating NCM professional
training, practice and public supply and to the absence of
government-promoted scientific research in this field. This
is an obstacle to safeguarding the patient’s interests and
freedom of choice, especially now that dissatisfaction with
biomedicine is inclining more and more people to look for a
holistic, fairer and patient-centred form of medicine.
Safeguarding people’s health, making treatment personal,
human and sustainable, presupposes that the patient be
central in choosing the therapy. Society has changed its
perception of quality in medicine and is demanding that
institutions humanize medicine: it must be both humanistic
and scientifically-based, hence person-centred medicine.
Diagnosing and treating each human being requires that we
find an individual centre of gravity taking the whole of the
person into consideration, their intrinsic unity, physical and
mental: the incessant interaction of these levels forms the
spiritual core of the human being, a unicum to be
interpreted before it can be cured.
There is an evident gap between a classic “healthcare
system” and a “pro-health system” of the kind needed to re-
programme public health in the teeth of worldwide
economic crisis. The traditional health system does not
cover the full implications of health: there are so many
significant factors that must be embraced by a pro-health
system. It is imperative that we integrate and liaise among
the various approaches to medicine as an art; a synergy
must be struck between biomedicine and anthropological or
traditional and non-conventional medicines, if we are to
achieve a sustainable equilibrium and contain the cost of
drugs.
It is no longer enough to learn about the origins of pathology;
traditional and non-conventional medicines share the commit-
ment to broadcast knowledge of how to generate health,
entailing studies on the sources of physical, psychological
and spiritual health; they share the ethical and social mission
to generate greater responsibility and social emancipation.
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Science stands in need of new paradigms of pluralism. That
challenge for the future extends beyond biomedicine: we
need to review the evidence-based approach and apply it to
traditional and non-conventional medicine. Not only are
the public health authorities still reticent about traditional
and non-conventional medicine, the whole health system
needs to set in motion a virtuous process whose central
aim should be global care of the individual patient–
person-centred medicine—a caring diachronic approach to
the psycho-patho-biological human being. Ethics demand
that we preserve, protect, promote, study, hand on and
apply the cultural heritage of medical and anthropological
health expertise, be it western or eastern, respecting the
original integrity of the tradition paradigms and patri-
monies. The epistemological status of medicine calls for
reformulation, and the key to hand is “person-centred
medicine”.
TIBETAN MEDICINE: A UNIQUE HERITAGE OF
PERSONALIZED MEDICINE
Roberti di Sarsina P1, Ottaviani L2
1High Council of Health, Ministry of Health, Italy;
Observatory and Methods for Health, Universtity of
Milano-Bicocca, Italy
2International Shang Shung Institute for Tibetan Studies,
Italy
With a history going back approximately 2500 years, the
Tibetan Medicine, known as Sowa Rigpa in the Tibetan
language, is one of the world’s oldest known Traditional
Medicine. It originally developed during the pre-Buddhist
era in the kingdom known as Shang Shung.
Over time it integrated religious influences and became the
basis of healing science in Tibet. In the 7th and 8th century the
Kings of Tibet promoted the exchange of healing knowledge
from outside the kingdom, and physicians from India, Nepal,
Persia and China came to Tibet to discuss their medical
systems. The result is believed to be a collection, in Tibetan, of
their combined medical knowledge, formalized in the Four
Tantras by Yutok Yonten Gonpo.
The fundamental theory of Tibetan Medicine sees a healthy
body composed of three humors, seven basic constituents
and three excretory substances. An unbalance in these
components then causes disease. Diagnosis is performed
through observation, palpation, questioning, urine, pulse,
and tongue analysis. It’s very interesting to point that
treatments not only cover the use of medicines, but also diet
and behavior along with physical therapies. Traditional
Tibetan Medicine is an ancient science in which some
of its fundamental principles are listening carefully to the
patient, a close global examination (body, mind, energy,
but also surrounding circumstances) and personalized
medical care.
Due to its cultural roots and to the approach based on the
specific identity of the patient in relation to his whole
environment (life history, personal issues, context and feel-
ings), Tibetan Medicine can be seen as a perfect example of
Person-Centred Medicine. In particular it enhances the
relationship between patient, doctor, and society as an
important aspect of health. The disease is considered in its
full dimensions with a primary focus on general mental health
and collaboration with one’s culture. In addition daily
integration of diet, prescribing particular foods to particular
people, is an effective method of preventive health as well as
for the treatment of mild disorders.
The Tibetan Medical Tradition has continued to grow into
modernity. After the Chinese invasion of Tibet, in 1961 His
Holiness the 14th Dalai Lama in exile re-established
(original created in Lhasa, 1916) the Men-Tsee-Khang,
Tibetan Medical and Astrology Institute, in Dharamsala,
India. Doctors there and abroad have had increases success
developing research and treatment for many illnesses,
especially those that have become chronic to which there
is no clear biomedical cures.
At present in China where Traditional Chinese Medicine is
not only well-developed but also part of the dominant
health system, Traditional Tibetan Medicine has been
accepted within the medical system as an autonomous
Traditional Medicine not being confused with TCM, and it is
slowly growing in popularity. Western countries have only
recently gained access to the Tibetan Buddhist texts which
provide some of the theoretical framework for Tibetan
medicine, with yet too few translations of the main texts
(including the four Tantras). At the same time schools of
Traditional Tibetan Medicine, recognized by the Tibetan
Medical and Astrology Institute, are slowly being created and
growing in US and Europe providing a useful source of
knowledge to both doctors willing to integrate them in Western
practice and patients seeking alternative healing modalities.
As a Traditional Medicine, the future development of Tibetan
Medicine inWestern countries is linked to being recognized as
popular and viable health care option providing an alternative
clinical reality. At the same time it is invaluable to preserve its
expression as both a culturally centered and holistic patient
based traditional medicine.
On Semptember 11th 2010 the ancient Tibetan medical
system was the core of the keynote lecture given by prof.
Chögyal Namkhai Norbu Rinpoche in the main hall of the
Institute of Anatomy of Bologna University.
Prof. Namkhai Norbu, one of the most important living
Masters of the Tibetan Tradition and Holder of the Dzogchen
Lineage, delivered a keynote address entitled “Tibetan
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Medicine, Heritage of the Mankind” in the Auditorium of the
Institute of Anatomy of the University of Bologna.
This was the first time that the Auditorium of the Institute
of Anatomy at Bologna University has been open for a
public address. http://www.dzogchen.it/press/?news_
it&n=1288540491_620
The event which was organized by the Associazione per la
Medicina Centrata sulla Persona Onlus (Association for
Person Centered Medicine, Onlus, a Charity established
according to the Italian Law) in collaboration with the
International Shang Shung Institute for Tibetan Studies, in
acknowledgement of its overall significance, has been
granted of highest level endorsements, among which The
European Association for Predictive, Preventive and Per-
sonalised Medicine and The European Medical Associa-
tion. http://www.dzogchen.it/lp/conferenza_2010-09-11/
index.php?lang=en
The International Shang Shung Institute was founded in
Italy in 1989 by Chögyal Namkhai Norbu Rinpoche, and
inaugurated in 1990 by His Holiness the 14th Dalai Lama.
It’s aim is to deepen the knowledge and understanding of
Tibetan cultural traditions in order to ensure their survival
and preservation. The International Institute currently has
three main branches, located in Italy, Austria, and the USA,
which work together as one to promote all initiatives to this
end. The mission of the Shang Shung Institute is to deepen the
knowledge and the understanding of the Tibetan cultural
traditions in its religious, historical, philosophical, artistic,
medical, and social aspects in order to contribute to the
survival and preservation of this culture. Its purpose is to
encourage cooperation among interested groups and individ-
uals, thus keeping alive the essential values of these traditions.
“The Shang Shung Institute exists for the preservation of
Tibetan Culture and to translate Tibetan books into Western
languages. Through the Shang Shung Institute we are trying
to do something to maintain the survival of Tibetan Culture
and understanding. Shang Shung, the name of the Institute,
reflects the source of Tibetan culture and history–it was
known as a great empire throughout the Orient and the
study of Shang Shung is extremely important if we are to
understand the great antiquity, the unique nature and the
universal importance of Tibetan Culture, past and present.”
Prof. Chögyal Namkhai Norbu Rinpoche, Founder of the
Shang Shung Institute
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TOWARDS SALUTOGENESIS IN THE DEVELOP-
MENT OFA PERSONALISED AND PREVENTATIVE
HEALTHCARE
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The purpose of this review is to discuss how a salutogenetic
approach may solve some of the difficulties faced by
healthcare systems. Salutogenesis explores the reasons why
some people stay healthy in the face of hazardous
influences whilst others, faced with the same hardship, fall
ill. It was Antonovsky who suggested that resilience to
difficult situations depends on a person’s sense of coherence
(SOC), a global orientation based on a sense of self-reliance
in the face of challenges, self-confidence in one’s ability to
deal with demanding events and the motivation to ‘keep
going’, trusting that such difficult events hold meaning for
one’s life [1,2]. There is a large body of research on all age
groups, different socioeconomic backgrounds and across
cultures that shows that a strong SOC is related to better
health and healthy ageing. It is a protective factor against
alcohol addiction despite similar rates of recreational
consumption in teenagers. Conversely, a weak SOC is
related to poorer health and lower affect. SOC is a dynamic
orientation that develops naturally in the first 30 years of
life but can also be strengthened through personal activity
and care [3–6].
How can a healthcare system be oriented so that overcom-
ing illness becomes the foundation of better future health?
In such a system each medical intervention should aim to
strengthen a person’s SOC and resilience and this should
be differentiated at each level from primary to tertiary
care. Each professional role too should be developed to
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provide salutogenetic care from their angle and this should
be addressed from as early as undergraduate training [7].
They should work towards the principles of person-
centred-medicine, a concept that aims to incorporate the
holistic approach, the relationship-based care and the
treatment systems of non-conventional medicine into the
technological advances of mainstream medicine in order
to provide more personalised and sustainable healthcare
[8,9].
The caregiver-person relationship needs to become central
to the therapeutic process so that any treatment is chosen as
an informed choice, based on the needs of that person in the
context of their physical, psychological and biographical
situation. As an example, if the chosen treatment were a
coronary artery bypass graft then the technological aspects
would need to be chosen specifically for that single case.
However for the whole process from pre-operative care
to rehabilitation to become a salutogenetic experience,
physical as well as psychological, social and personal
factors need to be addressed at the appropriate time. This
could develop the awareness that overcoming this difficult
experience was meaningful because it allowed the devel-
opment of new life skills, new coping strategies, and new
confidence in one’s healing abilities [10]. This change
needs to be sustained over time with appropriate follow-up
[11].
Adopting a healthier lifestyle is likely to improve the
quality of life of that person, and may prevent future
illness being cheaper in the long run for the healthcare
system. In order to evaluate the success of medical
interventions broadened with a salutogenetic approach,
parameters may need to be developed and adopted that
can assess quality of life of patients and caregivers in
terms of sustainable change, satisfaction and prevention
of burn-out as well as cost-effectiveness and technolog-
ical excellence [12].
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HELP4MOOD PROJECT: TECHNOLOGY TO
HELP IN PERSONALIZED MANAGEMENT OF
DEPRESSION
Mendive J1,2, Fernández A2, Rubio M2, Luciano JV2,
Baladón L2, Barreda V2, Serrano-Blanco A2, on behalf of
the Help4Mood Partnership
1Barcelona, Spain, EPMA Spanish National Representative
2Health Technology and Outcomes in Primary Care and
Mental Health Group, Research and development unit, Parc
Sanitari Sant Joan de Déu Sant Boi de Llobregat, Barcelona,
Spain
The aim of the Help4Mood project is to develop a system
that will help people with major depression recover in their
own home. The Help4Mood system is designed to be used
together with other forms of therapy, such as self-help,
counselling, or medication. Help4Mood has three main
components:
& a personal monitoring system that keeps track of
important aspects of behaviour such as sleep or activity
levels
& an interactive virtual agent who asks patients about their
health and well-being, provides a portal to trusted health
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information, and feeds back information collected
through monitoring and questionnaires
& a decision support system that tailors each session
with the virtual agent to the individual needs of
the person with depression and that supports
clinicians in interpreting the data collected through
the virtual agent and the personal monitoring
system.
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PERSONALITY’S PROFILES OF TEENAGERS AND
STUDENTS: ACOMPARATIVESTUDYPERFORMED
IN TIMISOARA, ROMANIA
Petrescu C, Suciu O, Ursoniu S, Vlaicu B
“Victor Babes” University of Medicine and Pharmacy,
Timisoara, Romania
Personality’s profil\es are established individually. Obser-
vation of a large group of persons with the same age offers
the possibility to establish what personality features are
pregnant for a specific stage of human development.
The aim of the study performed was to investigate the
features of the personality considering age group peculiar-
ities. The measurable objectives were: to realize individual
profiles of personalities and group profiles with relevance
of the pregnant features on age group; to relate pregnant
features of an age group with risk behaviors; to compare the
age group peculiarities in relation to risk behaviors between
teenagers and students.
The materials consisted of two samples: a sample of teenagers
(2908, 1498 girls and 1410 boys) and a sample of students
(2124, 1074 girls and 638 boys). There was a problem with
the second sample, were girls were more numerous than boys.
We used the method of an epidemiological inquiry based on
two questionnaires: CORT 2004 (with 126 items that
investigated smoking, alcohol and drug consumption, aggres-
sive behaviors, traffic accidents, sexual, feeding, sedentary
and self-medication behaviors) and Freiburg Personality
Inventory (FPI) with 212 items that investigated nervousness,
aggressiveness, depression, excitability, sociability, calm,
domination, inhibition, sincerity, emotional lability, bipolar
personality features. Both questionnaires were individually
applied, in one session and respecting anonymity.
Results obtained: Four personality’s dimensions presented
ranks over 6 (4–6 being considered balanced) in teenagers:
nervousness (rank 8), aggressiveness, excitability and
domination (rank 7 each of them). Two personality’s
dimensions were registered with high ranks in students:
nervousness and sincerity (rank 7, each of them). Risk
behaviors related with personality features in teenagers are:
smoking and alcohol consumption–the same profiles with
the sample; drug consumption–oscillation on the depression
dimension; hetero-aggressive behavior–increased ranks of
nervousness and aggressiveness; suicidal behavior–in-
creased level of depression and history of suicide in family
and also increased ranks of nervousness and aggressive-
ness, sexual behavior with risk–decreased domination,
decreased sociability and aggressiveness. There was a
tendency in teenagers to lie and exaggerate the number of
sexual partners. Risk behaviors related with personality
features in students are: smoking—the same profile with
the samples, alcohol and drug consumption–decreased level
of inhibition; hetero-aggressive behavior–oscillation of the
sociability dimension (introvert–physical aggressiveness,
extrovert–verbal aggressiveness), suicidal behaviors–no
pregnancy of features; sexual behavior with risk–high level
of sociability and of sincerity dimensions.
In conclusion, there are relevant differences between teen-
agers and students as far as personality features (students
are more balanced than teenagers) and risk behaviors are
concerned (in teenagers they are connected with instability
and in students they are connected with specific dimensions
of personality and they seem to be more persistent).
EVALUATION OF THE IMMUNIZATION STRATEGY
IMPLEMENTATION IN THE REPUBLIC OF
MACEDONIA IN 2004–2009
Kamchev N1, Zdravkovska M2, Ivanovska V1, Kamcheva G1
1Faculty of Medical Sciences, University Goce Delcev,
Stip, Republic of Macedonia
2Medical Faculty, University Ss. Cyril and Methodius,
Skopje, Republic of Macedonia
Introduction: The introduction of the vaccines as a
protective measure against infectious diseases shows
impressive results throughout the history of medicine.
Several infectious diseases have been eliminated globally,
while many others have been reduced to a negligible
amount. The mandatory immunization policy in the
Republic of Macedonia has achieved high coverage rates.
They are in line with the World Health Organization
recommendations and other referent international institu-
tions at levels≥95%, with rare reductions for some vaccines
below 95%, and even less occasionally below 90%.
Objectives: To evaluate the implementation of the
immunization program in the Republic of Macedonia
from 2004 to 2009, and to present the incidence and
prevalence of vaccine-preventable diseases for the same
period of time.
Methods and materials: We investigated the number of all
registered vaccinated and re-vaccinated people from 2004
to 2009 consistent with the national mandatory immuniza-
tion policy against certain infectious diseases. The study
also included figures on people infected with vaccine-
preventable diseases for the same period. The source of
relevant information was the Institute of Public Health of
the Republic of Macedonia. This was a descriptive
epidemiological study.
Results: The coverage rates for primary vaccination against
several infectious diseases in 2009 were above 95%. The
coverage rate of 96.4% for the three doses OPV vaccine in
2009 is higher than its average rate of 95.1% during the
period 2004–2008. The coverage rate of 95.9% for the three
doses DTP vaccine in 2009 is 1% higher than its average
rate during the period 2004–2008. The coverage rate of
95.8% for one dose MMR in 2009 is lower than its average
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rate of 97.8% during the period 2004–2008. The coverage
rates below 95% for these three vaccines were registered
only in 2006.
The coverage rates below 95% for primary vaccination
during the period 2004–2009 were registered for:
Hepatitis B vaccine (94.2%), Haemophilus influenzae
type b vaccine (81.5%) during 2008 and 2009, and for
Human Papillomavirus vaccine which was initiated in
November 2009. With the exception for MMR, all other
re-vaccinations in 2009 are below 95%, but above 90%,
which represent lower coverage rates compared with their
average rates for the period 2004–2008. From 2004 to
2009, the prevalence of Pertussis was 1.08 per 100,000
inhabitants, Measles 2.45 per 100,000 inhabitants,
Mumps 850.6 per 100,000 inhabitants (epidemic in
2008/2009), Rubella 6.68 per 100,000 inhabitants, and
Tetanus 0.19 per 100,000 inhabitants.
Conclusions: In Republic of Macedonia, the coverage rates
for the majority of vaccines against certain infectious
diseases included in the national mandatory immunization
policy are well at level of 95%. However, there is a slight
tendency of reduction in the coverage rates for primary
vaccination, as well as in the re-vaccination rates for certain
vaccines in 2009.
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